Skip to main content
. 2016 Jan 21;7(15):19499–19518. doi: 10.18632/oncotarget.6967

Table 2. Liver cancer precursor and cirrhosis cohorts used for Oncomine® Research Edition based analysis of TGF-β1 and TGF-β2 expression.

No. of cohort in Supplementary Figure 3 B + C Publication Reference Tissue
8 Mas Liver, Mol Med. 2008 [78] Cirhosis vs. normal
9 Wurmbach Liver, Hepatology 2007 [80] Cirhosis vs. normal
10 Wurmbach Liver, Hepatology 2007 [80] Dysplasia vs. normal
11 Chiang Liver 2, Cancer Res.2008 [81] HCC vs. Liver Cancer Type: Liver Cancer Precursor
12 Mas Liver, Mol Med. 2008 [78] HCC vs. Liver Cancer Type: Liver Cancer Precursor
13 Archer Liver, Cancer Epidemiol Biomarkers Prev. 2009 [82] HCC vs. Liver Cancer Type: Liver Cancer Precursor
14 Chen Liver. Mol Biol Cell. 2002 [76] HCC vs. Liver Cancer Type: Liver Cancer Precursor

Number of the respective cohorts in Supplementary Figure 3B and 3C as well as the respective publications and reference tissues are given.